NewsBenzingaAstraZeneca estende la partnership con Tempus AI con un impegno da 200 milioni di dollari mentre un analista valuta i multipli AstraZeneca estende la partnership con Tempus AI con un impegno da 200 milioni di dollari mentre un analista valuta i multipli Benzinga 2026.11.19 17:18 (GMT+0) Open on Benzinga Other news Morgan Stanley Maintains Overweight on Walt Disney, Raises Price Target to $138 What's Going On With Dell Technologies Stock Thursday? This Lowe’s Analyst Cites 7 Takeaways From Earnings Call Morgan Stanley Maintains Overweight on Target, Raises Price Target to $185 Plug Power CFO Reiterates Q4 2026 Positive EBITDAS Target AstraZeneca Extends Tempus AI Partnership with $200 Million Commitment as Analyst Weighs Multiples